Further, we analyzed tumor samples from mice responding to Torin2 treatment and found reduced phospho-4E-BP1 staining, as well as reduced staining for survivin (reduced nuclear staining) and HIF-1α, a marker of aggressive cancer (Figure 6C) [22, 23]. The gene discussed is HIF1A; the disease is neoplasm.